Gimsilumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Gimsilumab
Monoclonal antibody
Type ?
Source Human
Target colony stimulating factor 2
Clinical data
Synonyms MORAb-022
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6726H10428N1764O2184S38
Molar mass 152.1 g/mol

Gimsilumab (MORAb-022) (INN[1]) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis.

This drug was developed by Eisai Inc.[2]

References[edit]